Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

Stem Cell Research & Therapy(2021)10.1186/s13287-021-02272-2Source: DataRank Database

Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency is a research paper published in Stem Cell Research & Therapy (2021). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.57)OA: goldTopics (66)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Jasmina Esterlechner ORCID,Elke Niebergall‐Roth ORCID,Ulf Dehio,Samar Sadeghi ORCID,Hannes M. Schröder ORCID

Live enrichment

PubMed:33741066 PMC:PMC7980611 OpenAlex:https://openalex.org/W3138319201

National Institutes of Health/National Eye Institute

Grant: RO1EY025794, R24EY028767

NEI NIH HHS

Grant: R01 EY025794

NEI NIH HHS

Grant: R24 EY028767

National Institutes of Health

Grant: 3R01EY025794-02S1

ABCB5-positive stem cells for LSCD therapy

National Institutes of Health

Grant: 5R24EY028767-05

Multipotent ABCB5-positive cell therapeutics for corneal disease

FWCI

3.57

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://stemcellres.biomedcentral.com/counter/pdf/10.1186/s13287-021-02272-2

publisherhttps://stemcellres.biomedcentral.com/counter/pdf/10.1186/s13287-021-02272-2

publisherhttp://link.springer.com/content/pdf/10.1186/s13287-021-02272-2.pdf

publisherhttp://link.springer.com/article/10.1186/s13287-021-02272-2/fulltext.html

journalhttps://doi.org/10.1186/s13287-021-02272-2

Fields of Study

Corneal Surgery and TreatmentsOcular Surface and Contact LensCorneal surgery and disorders03 medical and health sciences0302 clinical medicineATP Binding Cassette Transporter, Subfamily BAnimalsCorneal DiseasesEpithelium, CornealHumansLimbus CorneaeProspective StudiesStem CellsTissue Distribution

MeSH Terms

AnimalsCorneal DiseasesHumansProspective StudiesStem CellsTissue DistributionLimbus CorneaeATP Binding Cassette Transporter, Subfamily BEpithelium, Corneal

Keywords

Stem cellLimbal stem cellTransplantationEx vivoMedicineDecellularizationProgenitor cellPopulationImmunologyCorneaBiologyPathologyCorneal epitheliumCancer researchCell biologyIn vivoExtracellular matrixSurgeryBiotechnologyOphthalmologyPax6p63limbal stem cellslimbal stem cell deficiencyAbcb5Advanced-therapy Medicinal ProductGmp ManufacturingMedicine (General)ATP Binding Cassette Transporter, Subfamily B610QD415-436Limbus CorneaeBiochemistryCorneal DiseasesR5-920Medicine and Health SciencesAnimalsHumansTissue DistributionProspective StudiesResearchStem CellsEpithelium, Corneal

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 2 of Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

10.6084/m9.figshare.14251893.v1figshare

Additional file 2 of Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

10.6084/m9.figshare.14251893figshare

Additional file 1 of Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

10.6084/m9.figshare.14251890.v1figshare

Additional file 1 of Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

10.6084/m9.figshare.14251890figshare

Additional file 1 of The application of a 4D-printed chitosan-based stem cell carrier for the repair of corneal alkali burns

10.6084/m9.figshare.25223562.v1figshare

Additional file 1 of The application of a 4D-printed chitosan-based stem cell carrier for the repair of corneal alkali burns

10.6084/m9.figshare.25223562figshare

Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

10.6084/m9.figshare.c.5346042figshare

Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

10.6084/m9.figshare.c.5346042.v1figshare

Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

FAIR Checklist

Authors (20)

Funding (5 grants)

Impact

Open Access

Topics

Linked Datasets (8)

Annotations (Europe PMC)